Resources
Blog Posts
Koneksa is at the forefront of digital biomarker discovery and testing, and our science-based understanding of their capabilities across therapeutic areas gives us a unique perspective. We are proud to share our insights, and we welcome your inquiries. Explore our articles to gain insights into the potential of digital biomarkers in clinical research.
Found 95 Results
Page 2 of 16
Article
5 Questions to Ask Before Choosing a Digital Biomarkers Partner
Introduction The adoption of digital biomarkers in clinical trials is accelerating rapidly, driven by wearable sensors, decentralized trial models, and the demand for continuous patient monitoring. As sponsors increasingly explore... Download
News
Koneksa Recognized in Multiple Independent Digital Biomarkers Market Reports Amid Accelerating Industry Growth
Inclusion across leading analyses reflects growing adoption of digital biomarkers and growing need for more rigorous measurement strategies in clinical development New York, NY — March 17, 2026 —... Download
Article
Designing Evidence That Reflects Everyone: A Black History Month Perspective
Diversity in clinical trials is not only a social imperative, it is a scientific standard. February, during Black History Month, offers an important moment to reflect on both the historical... Download
Article
Measurement Strategy First: Designing Fit-for-Purpose Digital Endpoints
Clinical development has never had more tools at its disposal. Wearables, sensors, mobile apps, imaging, biomarkers, and real-world data streams are increasingly used to generate digital endpoints in clinical trials,... Download
News
Celebrating Last Patient In for Koneksa’s Parkinson’s Disease Progression Study (KH007)
We are happy to announce that our clinical study KH007 (NCT06219629) of Disease Progression in Parkinson's Disease (PD) achieved the last patient in (LPI) on January 10, 2025. This is... Download
Article
Celebrating Last Patient In for Koneksa’s Parkinson’s Disease Progression Study (KH007)
We are happy to announce that our clinical study KH007 (NCT06219629) of Disease Progression in Parkinson's Disease (PD) achieved the last patient in (LPI) on January 10, 2025. This is... Download
